Inventor · disambiguated record
Stephen Charles Emery
Also filed as: EMERY STEPHEN C · EMERY STEPHEN CHARLES
8 granted patents·7 pending applications·105 citations·filing 1997–2016
87Inventor score
Top patents by PatentIndex Score
15 records- 0195US7973140B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2005·Granted Jul 5, 2011·36 cites·11 claims
- 0284US8834880B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2012·Granted Sep 16, 2014·5 cites·4 claims
- 0381US8026344B2Targeted binding agents directed to uPAR and uses thereofMEDIMMUNE LTD·Filed 2007·Granted Sep 27, 2011·6 cites·18 claims
- 0478US10066011B2Antibodies directed to angiopoietin-2 and uses thereofMEDIMMUNE LTD·Filed 2014·Granted Sep 4, 2018·2 cites·15 claims
- 0577US6903203B2Monoclonal antibody to CEA, conjugates comprising said antibody and their therapeutic useASTRAZENECA UK LTD·Filed 2001·Granted Jun 7, 2005·12 cites·12 claims
- 0673US6838446B1Vector for expression of GPI-enzyme hybridASTRAZENECA AB·Filed 2000·Granted Jan 4, 2005·3 cites·6 claims
- 0770US6339070B1Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moietyZENECA LTD·Filed 1998·Granted Jan 15, 2002·37 cites·34 claims
- 0858US2009123474A1Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or fltl antagonist for treating cancerASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 0955US2012288497A1Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancerBLAKEY DAVID CHARLES·Filed 2012·Application pending·0 cites
- 1054US2012052073A1Antibodies Directed to Angiopoietin-2 And Uses ThereofGREEN LARRY L·Filed 2011·Application pending·0 cites
- 1154US2016251421A1Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancerMEDIMMUNE LTD·Filed 2016·Application pending·0 cites
- 1252US2011097321A1Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancerASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 1352US2014023654A1Combination of angiopoietin-2 antagonist and of vegf-a, kdr and/or flt1 antagonist for treating cancerMEDLMMUNE LTD·Filed 2013·Application pending·0 cites
- 1442US2012108797A1Targeted binding agents directed to upar and uses thereofELVIN PAUL·Filed 2011·Application pending·0 cites
- 1540US6277599B1Anti-CEA antibody designated 806.077, hybridoma and method of manufactureZENECA LTD·Filed 1997·Granted Aug 21, 2001·4 cites·8 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →